πŸ‡ΊπŸ‡Έ FDA
Patent

US 11603519

T-cell receptor

granted A61KA61K35/17A61K40/11

Quick answer

US patent 11603519 (T-cell receptor) held by Takeda Pharmaceutical Company Limited expires Mon Mar 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Mar 14 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K35/17, A61K40/11, A61K40/32, A61K40/4261